- UCL Neuroscience rated top by research strength in the REF2014
- $5.9 million boost for SUDEP research
- Secret of tetanus toxicity offers new way to treat motor neuron disease
- Harm to others outweighs harm to self in moral decision making
- Auto anomaly detection for brain imaging awarded £1m grant
- Spinal surgery: OECs studies to start in 2015
- New brain tumour research Centre of Excellence is unveiled
- UCL awarded £13.5 million to advance medical research facilities
- UCL research helps paralysed man to recover function
- Stenting safe and effective for long-term stroke prevention
- Department of Clinical & Experimental Epilepsy re-designated as a WHO Collaborating Centre
- Leonard Wolfson Experimental Neurology Centre open evening
- Brain stimulation to improve cognition in dementia
- Professor Lees receives Jay Van Andel Award for Outstanding Research in Parkinson’s Disease
- Creating brain cells from skin to study Alzheimer's
- Queen Square authors prominent in Brain collection of classic articles
- Toxic proteins implicated in frontotemporal dementia and motor neurone disease
- GCH1 gene and Parkinson’s risk
- Double mutation linked to frontotemporal dementia
- Equation to predict happiness
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- BRC awards £700,000 to neuroscience projects
Published: Oct 22, 2014 9:52:00 AM
Published: Sep 16, 2013 1:37:21 PM
Published: Jan 21, 2015 12:20:24 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Jan 8, 2015 5:47:53 PM
Published: Jan 5, 2015 4:35:46 PM
Immune system implicated in dementia development
18 June 2014
The immune system and body’s response to damaged cells play a key role in the development of frontotemporal dementia (FTD), finds new research led by the UCL Institute of Neurology.
These findings will enable researchers to develop new treatments that target the body’s response to damaged cells. FTD is the second most common form of young-onset dementia after Alzheimer’s disease. The disease is caused when nerve cells in the frontal and/or temporal lobes of the brain die and the pathways connecting them change. In the majority of cases, the disease is not inherited.
We are trying to understand what causes or predisposes people to the non-inherited form of FTD. Even though the disease is sporadic (not inherited), there are genetic pre-dispositions. This study is the type where we can find those pre-disposing factors.
Professor John Hardy, co-leader of the study, NIHR Queen Square Dementia Biomedical Research Unit
The study, published in Lancet Neurology, involved more than 40 research groups from Europe, Australia and the US who contributed several thousand FTD cases for analysis.
study found evidence of two key processes driving FTD development.
The first is an out-of-control inflammatory process in the brain and the second is a lysosomal problem. Lysosomes are parts of the cell which are responsible for digesting damaged proteins. What we think this is telling us is that these damaged proteins are overwhelming the damage response part of the cell.
Professor John Hardy
This finding in FTD raises interesting parallels with Parkinson’s Disease, another neurodegenerative disease that has been linked to similar processes.
These findings provide the basis for future genetic and functional studies aimed at replicating these results, as well as shedding light on the molecular mechanisms that contribute to the pathogenesis of the disease
Lead author Dr Raffaele Ferrari
The study shows the value of international collaboration to amass the data needed. It also shows how much can be learned from one neurodegenerative disease which is of value to understanding others.
Professor Martin Rossor, Director of the NIHR Queen Square Dementia Biomedical Research Unit and NIHR National Research Dementia Professor
- Ferrari, R. et al. (2014) Frontotemporal dementia and its subtypes: a genome-wide association study Lancet Neurology, Volume 13, Issue 7, July 2014, Pages 686–699. DOI: 10.1016/S1474-4422(14)70065-1
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- Diagram showing areas of the brain affected by FTD
Page last modified on 18 jun 14 13:53